NCT03746548 is a NA clinical trial of Adhear in Conductive Hearing Loss, sponsored by Dominik Riss.

Who is sponsoring NCT03746548?

NCT03746548 is sponsored by Dominik Riss.

What drugs are being tested in NCT03746548?

Interventions in NCT03746548: Adhear, Contact Mini (CM).

What condition does NCT03746548 study?

NCT03746548 studies Conductive Hearing Loss.

Is NCT03746548 still recruiting?

NCT03746548 is currently completed. Last updated 2 January 2020.

Last reviewed 2020-01-02 · How we verify

NCT03746548

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Audiological Benefit and Quality of Life With Two Bone Conduction Systems: ADHEAR vs. Contact Mini

Completed NA Last updated 2 January 2020

What this trial tests

NA trial testing Adhear in Conductive Hearing Loss in 13 participants. Completed in 30 June 2019.

Timeline

1 January 2018

Primary endpoint
18 February 2019

30 June 2019

Quick facts

Lead sponsor	Dominik Riss
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	13
Start date	1 January 2018
Primary completion	18 February 2019
Estimated completion	30 June 2019
Sites	1 location across Austria

Drugs / interventions tested

Adhear
Contact Mini (CM)

Conditions studied

Conductive Hearing Loss — all drugs for Conductive Hearing Loss →

Sponsor

Dominik Riss

Who can join

Adults 13 to 99, any sex, with Conductive Hearing Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with conductive hearing loss fitting the inclusion criteria will be asked to participate in the study. All subjects will be randomized to wear either first the adhesive or the conventional bone conduction hearing aid. They will wear either device for two weeks. They will use the second device for another two weeks. Audiologic tests and quality of life questionnaires will be assessed at the beginning of the study after two weeks with the first device and after two weeks with the second device. Additionally, all patients will be asked to keep a diary including daily wearing time of the device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Dominik Riss trials

Trials by the same sponsor.

NCT03766152 — Audiological Benefit and Improved Quality of Life With Two Bone Conduction Systems: ADHEAR vs. Bonebridge in Experienced · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03746548 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dominik Riss
Last refreshed: 2 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03746548.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing